Alkermes

Alkermes

Community score

+1.35 -55
Industry: Biotechnology & Pharmaceuticals
Listing country: United States
Year added: 2018

Incorporated in 1987, Alkermes is headquartered in Dublin, Ireland, and is primarily engaged in developing, manufacturing, and marketing pharmaceuticals for the treatment of central nervous system (CNS) diseases and addiction. Their focus areas include CNS diseases such as schizophrenia, depression, and bipolar disorder. Among their most prominent brands are VIVITROL®, an injectable medication for alcohol dependence and prevention of opioid dependence relapse; ARISTADA®, an extended-release injectable antipsychotic for schizophrenia; and ARISTADA INITIO®, which is used for initiating or re-initiating treatment for schizophrenia in adults. Alkermes operates mainly in the United States, which represents its most significant market, though its products are also available internationally through various distribution partnerships or direct sales in specific countries. The range of products that Alkermes offers may change over time due to the introduction of new pharmaceuticals or the discontinuation of older ones. (Powered by AI)

Show Company Information
You view a limited profile page without scores and metrics availability. Subscribing users get to see more advanced data, want to see it in action? Click on a company you are interested in: .
My impact scoreBeta
List View

Research and development (R&D) investments are crucial to developing diagnostics, drugs, and vaccines that will improve and save people's lives and enhance health security1. Schizophrenia is a mental health condition in which people interpret real...

09.03.2022 - Impact Analyst Abdulmajeed V. January 22nd, 2024
22 ratings

Climate change, the growing population, and the shift toward clean energy is expected to cause freshwater deficiency, as in 2030 the world is expected to face a 40% gap between fresh water supply and demand9. Water scarcity is an issue for about 2...

02.06.2021 - Impact Analyst Oyelakin M. January 22nd, 2024
24 ratings

Pharmaceutical waste includes hazardous and non-hazardous wastes, including expired, unused, and used packaging1. Plastic takes hundreds of years to decompose, affecting wildlife species and killing marine mammals3. Cardboard takes over two months...

04.06.2021 - Impact Analyst Gift O. January 5th, 2024
12 ratings

Approximately 1.1% of the United States population is impacted by schizophrenia7;p10.Around 2 billion (Bn) people worldwide lack access to essential medications1;p1. At least 10% of the household budget of over 800 million (Mn) people goes into he...

04.11.2020 - Impact Analyst Manisha R. January 1st, 2024
18 ratings

The pharmaceutical industry plays a significant role in disease eradication and improving standards for R&D to find cures1. According to the WHO, 2 Bn people lack access to essential medicines globally2;p8. Diseases and illnesses are the leading c...

04.04.2021 - Impact Analyst Maria Amor M. November 16th, 2023
42 ratings

Discrimination makes it harder for minorities to meet basic financial requirements1. People are often discriminated against based on age, race, ethnicity, etc2. Increasing minority representation improves their economic and psychological health co...

15.08.2020 - Impact Analyst Renu R. November 14th, 2023
20 ratings

To ensure strong institutions and the well-being of society, governments spend a considerable amount of the state's budget on public goods & services, which are funded through taxes paid by individuals and corporations1. Corporate taxes accounted ...

04.03.2022 - Impact Analyst Deborah D. November 3rd, 2023
16 ratings

Around 3.4 billion people are employed worldwide, representing 44% of the global population1. Job creation is crucial for society, as well as for the economy2. Employ10ment facilitates poverty reduction and provides social protection for workers a...

14.02.2021 - Impact Analyst Ghulam G. August 2nd, 2023
18 ratings

In 2021, global GHG emissions amounted to 40.8 billion tonnes (t) of CO2e1;p11. To meet the goals of the Paris Agreement, from 2020 to 2030, annual GHG reductions of 7.6% are required2. The rapid increase in the emission of greenhouse gases is cau...

09.12.2021 - Impact Analyst Kanak _. June 13th, 2023
18 ratings

As per the ILO, to be gender-balanced, an organization needs 40-60% of either gender1;pxii. An upper ratio of women in the workplace forecasts more job satisfaction, meaningful work, dedication, and fewer burnouts2Conversely, women's underrepres...

09.12.2021 - Impact Analyst Kanak _. March 25th, 2023
36 ratings

Most negative / positive SDG